• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Alvimopan use in colorectal resection patients

Alvimopan use in colorectal resection patients

Erica Pettke1, Abhinit Shah1, Vesna Cekic1, Daniel Feingold2, Tracey Arnell2, Nipa Gandhi1, Carl Winkler, MD1, Richard Whelan1. 1Mount Sinai West, 2Columbia University

Introduction: Alvimopan (Alvim) is a peripherally acting µ-opioid receptor antagonist used to accelerate gastrointestinal functional recovery postoperatively (postop) after bowel resection.  The purpose of this retrospective study was to compare the time to first flatus and bowel movement (BM) as well as length of stay (LOS) following elective minimally invasive colorectal resection (CRR) in a group of patients (pts) who received alvimopan perioperatively (periop) vs a group that did not get this agent.

Methods: A data review from 2000-2015 from 2 IRB approved databases was carried out.  Operative, hospital and office charts were reviewed.  Routine use of Alvim for elective CRR cases was stared in 2013. Besides GI data, preoperative comorbidities and 30 day postop complication rates were assessed. The results with periop Alvim were compared to a no-Alvim group. The Students T and Chi-Square tests were used.

Results: A total of 902 pts underwent elective CRR.  Alvim was administered periop to 262 pts (29%).  The breakdown of indications between groups were similar. Alvim pts were younger (60.4 vs. 63.8 years old, p = 0.002) and, as regards comorbidities, less likely to have heart disease (CAD 4.1% vs 13.9%, other heart disease 13.2% vs 19.5%) but were otherwise similar. The rate of laparoscopic-assisted (Alvim, 80.9%; No Alvim, 68%) and hand assisted or hybrid operations (Alvim,  19.1%; No Alvim,  32%) were similar.  Alvim pts had significantly earlier return of flatus (2.4 vs 2.9 days) and first BM (2.6 vs 3.5, p<0.001 for both) than the No Alvim group.  There was also a trend toward a shorter LOS (6.1 vs 6.7 days, p=0.05) for the Alvim group.  Overall complication rates were similar, however, Alvim pts had lower rates of post-operative ileus (5.3% vs 14.1%, p < 0.0002), sSSI’s (5.8 vs 10%, p=0.04), and blood transfusion (7.1 vs 13.0%, p=0.01) than the No Alvim group.

Conclusion: The two groups compared were largely similar (most co-morbidities, indications, CRR type) with the differences in age and cardiac issues noted.  The impact of the higher rates of sSSI’s, blood transfusion, and MI in the no Alvim group on GI function is unclear.  Pts who received Alvim periop had an accelerated return of bowel function, decreased postoperative ileus and shorter length of stay.  These results suggest that Alvim is effective in reducing the postoperative ileus but further study is warranted.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87549

Program Number: P281

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

55

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals